Importance of entero-salivary recirculation in paracetamol pharmacokinetics.
The contribution of an entero-salivary recirculation (salivary secretion-swallowed-reabsorption of drug from the gastrointestinal tract) to the values of the pharmacokinetic parameters of paracetamol was studied in a two-way crossover design. Five healthy volunteers took a tablet of Paracetamol (500 mg) in two occasions separated by a washout period. The difference between the two treatments consisted of saliva that was allowed or not to be swallowed during the 4 h of study. No statistically significant differences were found in the values of the pharmacokinetic parameters between treatments. The half-life time calculated from salivary levels was similar to the values previously reported by other authors. The percent of the oral dose excreted in saliva during 4 h of study was very low (0.1%). Secondary peaks appeared in 8 of 10 profiles. The lack of influence of salivary secretion on the pharmacokinetic parameters of Paracetamol and the low percent secreted in this fluid suggests that entero-salivary recirculation is a possible physiological phenomenon undergoing after oral administration, but it is not one of the principal phenomenon that defines the pharmacokinetic of the drug. We confirm that working with salivary samples in pharmacokinetic studies of paracetamol is a useful tool.
Schaiquevich
Paula
P
Instituto de Investigaciones Farmacológias (ININFA-CONICET), Argentina. paulas@huemul.ffyb.uba.ar
Niselman
Ada
A
Rubio
Modesto
M
D000082:Acetaminophen / Q000493:pharmacokinetics*; D000328:Adult; D018712:Analgesics, Non-Narcotic / Q000493:pharmacokinetics*; D019540:Area Under Curve; D002851:Chromatography, High Pressure Liquid; D003679:Deglutition; D005260:Female; D006801:Humans; D007408:Intestinal Absorption; D008297:Male; D012463:Saliva / Q000378:metabolism*; D013997:Time Factors
D018712:Analgesics, Non-Narcotic; D000082:Acetaminophen